Symbol="CTMX"
AssetType="Common Stock"
Name="CytomX Therapeutics Inc"
Description="CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California."
CIK="1501989"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="116093000"
EBITDA="-64790000"
PERatio="None"
PEGRatio="-1.8"
BookValue="-1.306"
DividendPerShare="0"
DividendYield="0"
EPS="-1.03"
RevenuePerShareTTM="1.025"
ProfitMargin="-1.045"
OperatingMarginTTM="-0.994"
ReturnOnAssetsTTM="-0.158"
ReturnOnEquityTTM="-54.75"
RevenueTTM="67622000"
GrossProfitTTM="53163000"
DilutedEPSTTM="-1.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.599"
AnalystTargetPrice="2.48"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.447"
PriceToBookRatio="3.806"
EVToRevenue="0.743"
EVToEBITDA="0.694"
Beta="0.622"
num_52WeekHigh="3.02"
num_52WeekLow="1.17"
num_50DayMovingAverage="1.712"
num_200DayMovingAverage="1.808"
SharesOutstanding="66339000"
DividendDate="None"
ExDividendDate="None"
symbol="CTMX"
open="1.72"
high="1.76"
low="1.67"
price="1.75"
volume="212111.00"
latest_trading_day="2023-07-28"
previous_close="1.71"
change="0.04"
change_percent="2.3392%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="76"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="24"
Volume_recent_avg="585865"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="24"
Aroon_momentum_negative="76"
image_negative_thumbnail_id_1="491"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_negative_thumbnail_id_2="494"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="607"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_positive_thumbnail_id_2="964"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
